Daniel DiCara
Impact in
- Cancer Research top 0.05%
- Cancer Genomics and Diagnostics
- Oncology top 0.1%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Cancer Genomics and Diagnostics 8
-
- Lung Cancer Treatments and Mutations 3
- Renal cell carcinoma treatment 2
- Journals
- Nature (7 papers)Cell (4 papers)Cancer Cell (1 paper)Nature Biotechnology (1 paper)Proceedings of the National Academy of Sciences (1 paper)
- Partner nations
- United StatesCanadaPoland
In The Last Decade
Daniel DiCara
16 papers receiving 34.6k citations
Daniel DiCara's Hit Papers
Peers
Comparison fields: 5 of 151
- Cancer Research 9.7k
- Oncology 10.0k
- Pulmonary and Respiratory Medicine 8.8k
- Genetics 2.5k
- Molecular Biology 16.3k
Countries citing papers authored by Daniel DiCara
This map shows the geographic impact of Daniel DiCara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel DiCara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel DiCara more than expected).
Fields of papers citing papers by Daniel DiCara
This network shows the impact of papers produced by Daniel DiCara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel DiCara. The network helps show where Daniel DiCara may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Comprehensive molecular characterization of gastric adenocarcinoma Hit paper breakdown → | 2014 | 5209 |
| 2 | Comprehensive molecular profiling of lung adenocarcinoma Hit paper breakdown → | 2014 | 4550 |
| 3 | Mutational heterogeneity in cancer and the search for new cancer-associated genes Hit paper breakdown → | 2013 | 4266 |
| 4 | The Somatic Genomic Landscape of Glioblastoma Hit paper breakdown → | 2013 | 3977 |
| 5 | Comprehensive genomic characterization of squamous cell lung cancers Hit paper breakdown → | 2012 | 3290 |
| 6 | Comprehensive molecular characterization of clear cell renal cell carcinoma Hit paper breakdown → | 2013 | 2829 |
| 7 | Genomic Classification of Cutaneous Melanoma Hit paper breakdown → | 2015 | 2509 |
| 8 | Integrated Genomic Characterization of Papillary Thyroid Carcinoma Hit paper breakdown → | 2014 | 2442 |
| 9 | Comprehensive molecular characterization of urothelial bladder carcinoma Hit paper breakdown → | 2014 | 2419 |
| 10 | A Landscape of Driver Mutations in Melanoma Hit paper breakdown → | 2012 | 2138 |
| 11 | The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma Hit paper breakdown → | 2014 | 659 |
| 12 | 2013 | 336 | |
| 13 | 2014 | 325 | |
| 14 | 2016 | 77 | |
| 15 | Comprehensive molecular profiling of lung adenocarcinoma | 2014 | 38 |
| 16 | 2013 | 1 |
About Daniel DiCara
Daniel DiCara is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology, Pathology and Forensic Medicine and Otorhinolaryngology, having authored 16 papers that have together received 35.1k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (8 papers), Lung Cancer Treatments and Mutations (3 papers), Renal cell carcinoma treatment (2 papers), Genetic factors in colorectal cancer (2 papers), RNA modifications and cancer (2 papers), Bioinformatics and Genomic Networks (2 papers), Melanoma and MAPK Pathways (2 papers) and BRCA gene mutations in cancer (2 papers). The work is most often cited by research in Cancer Research (9.7k citations), Oncology (10.0k citations), Pulmonary and Respiratory Medicine (8.8k citations), Genetics (2.5k citations) and Molecular Biology (16.3k citations). Daniel DiCara has collaborated with scholars based in United States, Canada and Poland. Their work appears in journals such as Nature, Cell, Cancer Cell, Nature Biotechnology and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.